At the completion of the clinical evaluation and based on the information received, there was substantial evidence to support the following observations: the type iiib endoleak of the bifurcated device complaint is refuted and rather, there was noted contrast billowing (within acceptable range), stent cage buckling, and no aneurysm (sac) growth.The stent cage buckling was observed at one-month post initial implant.Procedure related harms and device, user, procedure, or anatomy relatedness of this complaint could not be determined.The final patient status was reported in good condition.
|